Biologic lung volume reduction therapy for advanced homogeneous emphysema

European Respiratory Journal

Volumn 36, Issue 1, 2010, Pages 20-27

  Refaely, Y ^a   Dransfield, M ^b   Kramer, M R ^a   Gotfried, M ^c   Leeds, W ^d   McLennan, G ^e   Tewari, S ^f   Krasna, M ^g   Criner, G J ^h  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Pulmonary Associates   (United States)

^d Veritas Clinical Specialties   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f Children's Hospital Medical Center of Akron   (United States)

^g St Joseph Medical Center   (United States)

^h TEMPLE UNIVERSITY   (United States)

Author keywords

Bronchoscopic lung volume reduction; Emphysema therapy; Homogeneous emphysema; Interventional pulmonology; Lung volume reduction surgery

Indexed keywords

FIBRIN; FIBRIN GLUE;

ADULT; AGED; ARTICLE; BIOLOGIC LUNG VOLUME REDUCTION; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL TRIAL; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYDROGEL; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG VOLUME; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; TREATMENT RESPONSE; BIOLOGICAL THERAPY; LUNG RESECTION; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROCEDURES; PULMONARY EMPHYSEMA; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; BIOLOGICAL THERAPY; BRONCHOSCOPY; DYSPNEA; EXERCISE; FEMALE; FIBRIN TISSUE ADHESIVE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; PULMONARY EMPHYSEMA; QUALITY OF LIFE; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 77954641058     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00106009     Document Type: Article

References (22)

1. Date H, Goto K, Souda R, et al. Predictors of improvement in FEV1 (forced expiratory volume in 1s) after lung volume reduction surgery. Surg Today 2000; 30: 328-332. (Pubitemid 30241139)
2. DeCamp MM Jr, Lipson D, Krasna M, et al. The evaluation and preparation of the patient for lung volume reduction surgery. Proc Am Thorac Soc 2008; 5: 427-431. (Pubitemid 351669165)
3. McKenna RJ Jr, Gelb A, Brenner M. Lung volume reduction surgery for chronic obstructive pulmonary disease: where do we stand? World J Surg 2001; 25: 231-237.
4. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073. (Pubitemid 36583301)
5. Wood DE. Results of lung volume reduction surgery for emphysema. Chest Surg Clin N Am 2003; 13: 709-726. (Pubitemid 37487026)
6. Martinez FJ, Chang A. Surgical therapy for chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005; 26: 167-191. (Pubitemid 40617295)
7. Ramsey SD, Berry K, Etzioni R, et al. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003; 348: 2092-2102. (Pubitemid 36583305)
8. Criner GJ, Sternberg AL. National Emphysema Treatment Trial: the major outcomes of lung volume reduction surgery in severe emphysema. Proc Am Thorac Soc 2008; 5: 393-405. (Pubitemid 351669160)
9. Criner GJ, Pinto-Plata V, Strange C, et al. Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. Am J Respir Crit Care Med 2009; 179: 791-798.
10. Ingenito EP, Berger RL, Henderson AC, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med 2003; 167: 771-778. (Pubitemid 36801757)
11. Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc 2008; 5: 454-460. (Pubitemid 351669170)
12. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345: 1075-1083.
13. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
14. Aggarwal AN, Agarwal R. The new ATS/ERS guidelines for assessing the spirometric severity of restrictive lung disease differ from previous standards. Respirology 2007; 12: 759-762. (Pubitemid 47414874)
15. ATS Committee for Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
16. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003; 167: 1287.
17. Washko GR, Criner GJ, Mohsenifar Z, et al. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD 2008; 5: 177-186.
18. Kohl G. The evolution and state-of-the-art principles of multislice computed tomography. Proc Am Thorac Soc 2005; 2, 470-476: 499-500.
19. Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest 2007; 131: 1108-1113.
20. Fessler HE, Scharf SM, Ingenito EP, et al. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc 2008; 5: 416-420.
21. Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg 2004; 127: 1564-1573.
22. Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thorac Cardiovasc Surg 2007; 134: 974-981. (Pubitemid 47454624)